Does GABAPENTIN Cause Neuroleptic malignant syndrome? 74 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Neuroleptic malignant syndrome have been filed in association with GABAPENTIN (Gabapentin). This represents 0.1% of all adverse event reports for GABAPENTIN.
74
Reports of Neuroleptic malignant syndrome with GABAPENTIN
0.1%
of all GABAPENTIN reports
23
Deaths
43
Hospitalizations
How Dangerous Is Neuroleptic malignant syndrome From GABAPENTIN?
Of the 74 reports, 23 (31.1%) resulted in death, 43 (58.1%) required hospitalization, and 29 (39.2%) were considered life-threatening.
Is Neuroleptic malignant syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does GABAPENTIN Cause?
Drug ineffective (10,914)
Drug hypersensitivity (6,833)
Off label use (6,729)
Drug ineffective for unapproved indication (5,231)
Product use in unapproved indication (4,919)
Toxicity to various agents (4,839)
Completed suicide (4,111)
Dizziness (4,107)
Somnolence (3,798)
Fatigue (3,791)
What Other Drugs Cause Neuroleptic malignant syndrome?
QUETIAPINE (1,756)
OLANZAPINE (1,748)
RISPERIDONE (1,258)
HALOPERIDOL (1,244)
ARIPIPRAZOLE (1,138)
CLOZAPINE (899)
LITHIUM (506)
LORAZEPAM (437)
PALIPERIDONE (355)
VALPROIC ACID (352)
Which GABAPENTIN Alternatives Have Lower Neuroleptic malignant syndrome Risk?
GABAPENTIN vs GABAPENTIN ENACARBIL
GABAPENTIN vs GADAVIST
GABAPENTIN vs GADOBENATE DIMEGLUMINE
GABAPENTIN vs GADOBUTROL
GABAPENTIN vs GADODIAMIDE